Credit Suisse Starts Endocyte (ECYT) at Outperform
Tweet Send to a FriendGet Alerts ECYT Hot Sheet
Price: $14.02 --0%
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade ECYT Now!
Credit Suisse initiates coverage on Endocyte (NASDAQ: ECYT) with a Outperform. PT $16.00.
For an analyst ratings summary and ratings history on Endocyte click here. For more ratings news on Endocyte click here.
Shares of Endocyte closed at $9.32 yesterday, with a 52 week range of $3.30-$10.97.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Endocyte click here. For more ratings news on Endocyte click here.
Shares of Endocyte closed at $9.32 yesterday, with a 52 week range of $3.30-$10.97.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Deutsche Bank Starts Alnylam Pharmaceuticals (ALNY) at Buy
- Topeka Capital Starts Diodes (DIOD) at Buy
- Maxim Group Starts Canadian Solar (CSIQ) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Credit Suisse
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
